The Swedish professor Emeritus in Infectious Diseases at Karolinska Institutet is interviewed about his memories and work as infectious disease physician in the 1980’s.

A short history of HIV and AIDS in Sweden, based on clips from the FoA archive.

Two interviews with Dr Mervyn Silverman, from 1988 and 2008. He explains the San Francisco model, how it began and what others can learn from it.

Interview with David Cooper, Director of The Kirby Institute at the University of New South Wales.

XIX International AIDS Conference in Washington D.C. Barton Haynes from the Duke Human Vaccine Institute (DHVI) has been working in the HIV vaccine field since 1985. Here he talks about the scientific difficulties of finding an HIV vaccine.

XIX International AIDS Conference in Washington D.C. Interview with the French Virologist, Françoise Barré-Sinoussi, winner of the Nobel Prize in Physiology or Medicine 2008 for discovering HIV as the cause of AIDS. Here she talks about the possibility of ending AIDS.

XIX International AIDS Conference in Washington D.C. Interview with the French Virologist, Françoise Barré-Sinoussi, winner of the Nobel Prize in Physiology or Medicine 2008 for discovering HIV as the cause of AIDS. Here she talks about the possibility of ending AIDS.

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Interview with three pioneers in the HIV/AIDS response - Dr Mervyn Silverman, Dr Paul Volberding, and Dr Lars Olof Kallings. They talk about the history of the AIDS movement.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Katharina Lindahl, Secretary General of RFSU, talks about the Swedish HIV prevention campaigns by RFSU and Aidsdelegationen in the early 1990's, and the importance of targeting youth of today with messages of HIV prevention.